Dexmedetomidine for Postoperative Sedation Following Stereotactic Lead Placement

Hope Xu; Anthony H. Bui; Maite La Vega-Talbott; Sheemon P. Zackai

doi:10.1055/s-0039-1687882

Dexmedetomidine for Postoperative Sedation Following Stereotactic Lead Placement

Hope Xu, Anthony H. Bui, Maite La Vega-Talbott, Sheemon P. Zackai

Research output: Contribution to journal › Article › peer-review

Abstract

Dexmedetomidine has become an increasingly popular alternative to benzodiazepines and opioids as a safe agent for sedation and pain control, especially in pediatric populations. In this study, we present a case of postoperative use of dexmedetomidine in a pediatric patient, with a known history of behavioral difficulties, who underwent stereotactic lead placement for medically refractory epilepsy.

Original language	English
Pages (from-to)	157-160
Number of pages	4
Journal	Journal of Pediatric Neurology
Volume	18
Issue number	3
DOIs	https://doi.org/10.1055/s-0039-1687882
State	Published - 1 Jun 2020

Keywords

Precedex
dexmedetomidine
epilepsy
sedation
stereoelectroencephalography
stereotactic lead placement

Access to Document

10.1055/s-0039-1687882

Cite this

@article{b3a9f6d8a7d74feba84ec6f5666815e3,

title = "Dexmedetomidine for Postoperative Sedation Following Stereotactic Lead Placement",

abstract = "Dexmedetomidine has become an increasingly popular alternative to benzodiazepines and opioids as a safe agent for sedation and pain control, especially in pediatric populations. In this study, we present a case of postoperative use of dexmedetomidine in a pediatric patient, with a known history of behavioral difficulties, who underwent stereotactic lead placement for medically refractory epilepsy.",

keywords = "Precedex, dexmedetomidine, epilepsy, sedation, stereoelectroencephalography, stereotactic lead placement",

author = "Hope Xu and Bui, {Anthony H.} and {La Vega-Talbott}, Maite and Zackai, {Sheemon P.}",

note = "Publisher Copyright: {\textcopyright} 2020 by Georg Thieme Verlag KG, Stuttgart • New York.",

year = "2020",

month = jun,

day = "1",

doi = "10.1055/s-0039-1687882",

language = "English",

volume = "18",

pages = "157--160",

journal = "Journal of Pediatric Neurology",

issn = "1304-2580",

publisher = "Thieme Medical Publishers Inc.",

number = "3",

}

TY - JOUR

T1 - Dexmedetomidine for Postoperative Sedation Following Stereotactic Lead Placement

AU - Xu, Hope

AU - Bui, Anthony H.

AU - La Vega-Talbott, Maite

AU - Zackai, Sheemon P.

PY - 2020/6/1

Y1 - 2020/6/1

N2 - Dexmedetomidine has become an increasingly popular alternative to benzodiazepines and opioids as a safe agent for sedation and pain control, especially in pediatric populations. In this study, we present a case of postoperative use of dexmedetomidine in a pediatric patient, with a known history of behavioral difficulties, who underwent stereotactic lead placement for medically refractory epilepsy.

AB - Dexmedetomidine has become an increasingly popular alternative to benzodiazepines and opioids as a safe agent for sedation and pain control, especially in pediatric populations. In this study, we present a case of postoperative use of dexmedetomidine in a pediatric patient, with a known history of behavioral difficulties, who underwent stereotactic lead placement for medically refractory epilepsy.

KW - Precedex

KW - dexmedetomidine

KW - epilepsy

KW - sedation

KW - stereoelectroencephalography

KW - stereotactic lead placement

UR - http://www.scopus.com/inward/record.url?scp=85085369616&partnerID=8YFLogxK

U2 - 10.1055/s-0039-1687882

DO - 10.1055/s-0039-1687882

M3 - Article

AN - SCOPUS:85085369616

SN - 1304-2580

VL - 18

SP - 157

EP - 160

JO - Journal of Pediatric Neurology

JF - Journal of Pediatric Neurology

IS - 3

ER -

Dexmedetomidine for Postoperative Sedation Following Stereotactic Lead Placement

Abstract

Keywords

Access to Document

Fingerprint

Cite this